[Tuberculous epididymitis following intravesical Bacillus Calmette-Guérin therapy].

Nihon Hinyokika Gakkai Zasshi

Department of Urology, Chikushi Hospital, Fukuoka University, Chikushino, Japan.

Published: May 2002

Bacillus Calmette-Guérin (BCG) immunotherapy is increasingly being accepted for management of some bladder transitional cell neoplastic lesions. Mild adverse reactions occur frequently. However, an unusual complication of tuberculous epididymitis is reported. A 64-year old man presented with bilateral epididymal mass. Four months earlier he had seven treatments with intravesical BCG instillation (Tokyo 172 strain) for a grade 2 transitional cell carcinoma in situ. Bilateral epididymectomy was performed. Microscopic examination of the epididymis revealed chronic inflammation and necrosis with granulomas and Langhans' giant cells. After the operation, there were no further complications.

Download full-text PDF

Source
http://dx.doi.org/10.5980/jpnjurol1989.93.580DOI Listing

Publication Analysis

Top Keywords

bacillus calmette-guérin
8
transitional cell
8
[tuberculous epididymitis
4
epididymitis intravesical
4
intravesical bacillus
4
calmette-guérin therapy]
4
therapy] bacillus
4
calmette-guérin bcg
4
bcg immunotherapy
4
immunotherapy increasingly
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!